Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study

Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study

Tatsunori Kiriu, Masatsugu Yamamoto, Tatsuya Nagano, Daisuke Hazama, Reina Sekiya, Masahiro Katsurada, Naoko Katsurada, Motoko Tachihara, Kazuyuki Kobayashi, Yoshihiro Nishimura Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Chuo-ku, K...

Full description

Bibliographic Details
Main Authors: Kiriu T, Yamamoto M, Nagano T, Hazama D, Sekiya R, Katsurada M, Katsurada N, Tachihara M, Kobayashi K, Nishimura Y
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:OncoTargets and Therapy
Subjects:
pseudo-progression
biomarker
neutrophil-to-lymphocyte ratio
immune checkpoint inhibitor
non-small cell lung cancer
Online Access:https://www.dovepress.com/pseudo-progression-and-the-neutrophil-to-lymphocyte-ratio-in-non-small-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/pseudo-progression-and-the-neutrophil-to-lymphocyte-ratio-in-non-small-peer-reviewed-article-OTT

Similar Items